NCT01903486View on ClinicalTrials.gov

Assessing the Efficacy of Steroid Treatment of Achalasia

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2013

Primary Completion Date

December 28, 2020

Study Completion Date

December 28, 2020

Conditions
Achalasia
Interventions
DRUG

Apo-Prednisone Cordorol, Detasone - Prednisone

Oral prednisone (study medication) at a dose of 40mg for 1 week, then 30mg for 1 week, then 20mg for 1 week, then 10mg for 1 week, and then stop the medication.

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01903486 - Assessing the Efficacy of Steroid Treatment of Achalasia | Biotech Hunter | Biotech Hunter